Resources Library
Does Your CRO Innovate To Keep Trials On Track?
ARG knows from experience that the willingness to be flexible has fueled our success in rare disease clinical trials, resulting in approvals with over $3B in sales.
May 9, 2018
ARG successfully starts up a Phase II trial within 6 weeks
Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and […]
May 1, 2018
Shay Brill: Judge for Clinical Researcher of the Year Competition
Shay Brill, ARG Vice President of Corporate Development, recently had the privilege and distinction of serving as a judge in […]
April 30, 2018
"ARG has strong relationships with the leading investigators in the PI arena"
The IDF (Immune Deficiency Foundation) fosters understanding and provides resources concerning PI (Primary Immunodeficiency) disease. ARG joins IDF in recognizing […]
April 28, 2018
Is Your CRO a Genuine Operational Partner?
ARG's history of successfully operationalizing rare disease clinical research has been driven by comprehensive engagement with our sponsors.
April 6, 2018
ARG and Agile: An Innovative Approach
Morten T. Hansen wrote an essay for the Wall Street Journal called “How to Succeed in Business? Do Less.” We […]
March 28, 2018